Pressroom

Filter by
PressroomApril 2, 2025

Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio

Mikael Dolsten, MD, PhD, former Chief Scientific Officer and President, Pfizer Research & Development will serve as Formation Bio's Chair of the Drug Picking Committee, Co-Chair of the Investment Advisory Committee, and Chair of Science, Technology, and Product Planning Committee

Read More
PressroomNovember 12, 2024

Introducing Muse

Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development.

Read More
© Formation Bio 2025
Site Credit